{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:27:48Z","timestamp":1781645268337,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T00:00:00Z","timestamp":1695513600000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011218","name":"Sandoz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.dmpk.2022.100473","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T12:16:57Z","timestamp":1661343417000},"page":"100473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Drug transporters are implicated in the diffusion of tacrolimus into the T lymphocyte in kidney and liver transplant recipients: Genetic, mRNA, protein expression, and functionality"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5417-5629","authenticated-orcid":false,"given":"Gwendal","family":"Coste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1234-5351","authenticated-orcid":false,"given":"Fabien","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6309-3986","authenticated-orcid":false,"given":"Jonathan","family":"Chemouny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1030-1750","authenticated-orcid":false,"given":"Camille","family":"Tron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-6655","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Le Priol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Le V\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9271-9810","authenticated-orcid":false,"given":"Pauline","family":"Houssel-Debry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3113-2260","authenticated-orcid":false,"given":"Michel","family":"Rayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6595-8154","authenticated-orcid":false,"given":"Marie-Cl\u00e9mence","family":"Verdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-0668","authenticated-orcid":false,"given":"Mikael","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0095-742X","authenticated-orcid":false,"given":"Marie-Dominique","family":"Galibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-0710","authenticated-orcid":false,"given":"Edouard","family":"Bardou-Jacquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5657-4255","authenticated-orcid":false,"given":"Olivier","family":"Fardel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-0656","authenticated-orcid":false,"given":"C\u00e9cile","family":"Vigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3894-8767","authenticated-orcid":false,"given":"Karim","family":"Boudjema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-6708","authenticated-orcid":false,"given":"Bruno","family":"Laviolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-3629","authenticated-orcid":false,"given":"Florian","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.dmpk.2022.100473_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"issue":"25","key":"10.1016\/j.dmpk.2022.100473_bib2","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.dmpk.2022.100473_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aor.13551","article-title":"Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity","volume":"44","author":"Bentata","year":"2020","journal-title":"Artif Organs"},{"issue":"5","key":"10.1016\/j.dmpk.2022.100473_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/FTD.0000000000000779","article-title":"Redefining therapeutic drug monitoring of tacrolimus in patients undergoing liver transplantation: a target trough concentration of 4-7 ng\/mL during the first month after liver transplantation is safe and improves graft and renal function","volume":"42","author":"Lemaitre","year":"2020","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.dmpk.2022.100473_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","article-title":"Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study","volume":"25","author":"Capron","year":"2012","journal-title":"Transpl Int"},{"issue":"6","key":"10.1016\/j.dmpk.2022.100473_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.clinbiochem.2014.12.018","article-title":"Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells","volume":"48","author":"Lemaitre","year":"2015","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1016\/j.dmpk.2022.100473_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/pgs.10.43","article-title":"CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation","volume":"11","author":"Capron","year":"2010","journal-title":"Pharmacogenomics"},{"issue":"15","key":"10.1016\/j.dmpk.2022.100473_bib8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.clinbiochem.2013.02.011","article-title":"Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients","volume":"46","author":"Lemaitre","year":"2013","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1016\/j.dmpk.2022.100473_bib9","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/bcp.14585","article-title":"Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients","volume":"87","author":"Francke","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.dmpk.2022.100473_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40262-018-0717-7","article-title":"Pharmacogenetics of membrane transporters of tacrolimus in solid organ transplantation","volume":"58","author":"Tron","year":"2019","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.dmpk.2022.100473_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics8020012","article-title":"Evaluation of P-glycoprotein inhibitory potential using a rhodamine 123 accumulation assay","volume":"8","author":"Jouan","year":"2016","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.dmpk.2022.100473_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pharmaceutics9010003","article-title":"Drug transporter expression and activity in human hepatoma HuH-7 cells","volume":"9","author":"Jouan","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.dmpk.2022.100473_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114103","article-title":"Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in\u00a0vitro and in\u00a0vivo: perspectives for scleroderma-associated interstitial lung disease","volume":"178","author":"Lescoat","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmpk.2022.100473_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2013.12.004","article-title":"Differentiation of human placental BeWo cells by the environmental contaminant benzo(a)pyrene","volume":"210","author":"Le Vee","year":"2014","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.dmpk.2022.100473_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/pharmaceutics10040246","article-title":"mRNA expression and activity of nucleoside transporters in human hepatoma HepaRG cells","volume":"10","author":"Mayati","year":"2018","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.dmpk.2022.100473_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230195","article-title":"Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients","volume":"15","author":"Tron","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.dmpk.2022.100473_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.transproceed.2012.10.023","article-title":"Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation","volume":"45","author":"Chakkera","year":"2013","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.dmpk.2022.100473_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clpt.2005.09.013","article-title":"Intestinal MDR1\/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients","volume":"79","author":"Masuda","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.dmpk.2022.100473_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00280-006-0357-8","article-title":"Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins","volume":"60","author":"Pawarode","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"10.1016\/j.dmpk.2022.100473_bib20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/ajt.14040","article-title":"Predictive modeling of tacrolimus dose requirement based on high-throughput genetic screening","volume":"17","author":"Damon","year":"2017","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.dmpk.2022.100473_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/cpt.1008","article-title":"Endogenous metabolites-mediated communication between OAT1\/OAT3 and OATP1B1 may explain the association between SLCO1B1 SNPs and methotrexate toxicity","volume":"104","author":"Martinez","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dmpk.2022.100473_bib22","doi-asserted-by":"crossref","first-page":"R1357","DOI":"10.1152\/ajpregu.00630.2005","article-title":"ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast","volume":"290","author":"Evseenko","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"10.1016\/j.dmpk.2022.100473_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11095-020-2782-5","article-title":"S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) is not a selective inhibitor of equilibrative nucleoside transporters but also blocks efflux activity of breast cancer resistance protein","volume":"37","author":"Karbanova","year":"2020","journal-title":"Pharm Res (N Y)"},{"issue":"11","key":"10.1016\/j.dmpk.2022.100473_bib24","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/cancers12113352","article-title":"Physiological roles of ERM proteins and transcriptional regulators in supporting membrane expression of efflux transporters as factors of drug resistance in cancer","volume":"12","author":"Ogihara","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.dmpk.2022.100473_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2217\/bmm-2017-0128","article-title":"SLC28A3 rs7853758 as a new biomarker of tacrolimus elimination and new-onset hypertension in Chinese liver transplantation patients","volume":"11","author":"Liu","year":"2017","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.dmpk.2022.100473_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-12-385493-3.00011-5","article-title":"Flow cytometry-based pharmacodynamic monitoring after organ transplantation","volume":"103","author":"Dieterlen","year":"2011","journal-title":"Methods Cell Biol"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436722000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436722000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:56:17Z","timestamp":1761162977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436722000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":26,"alternative-id":["S1347436722000301"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2022.100473","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug transporters are implicated in the diffusion of tacrolimus into the T lymphocyte in kidney and liver transplant recipients: Genetic, mRNA, protein expression, and functionality","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2022.100473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100473"}}